0844 (0844) Fair Value & Analysis

Consumer Cyclical · Market cap HK$205M

0 0844 0844 · HK

PriceHK$0.4150

Fair ValueHK$0.2600

Upside-37.3%

Quality46/100

Evidence: Low Range HK$0.1900 – HK$0.3800

Fair value as of: Jul 2, 2026

From 1 valuation models · updated today

Share price −4.6% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.2950 – HK$0.6300 · fair‑value band HK$0.1900 – HK$0.3800 · the HK$0.4150 price screens above the HK$0.2600 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

0844 (0844) currently trades at HK$0.4150, while our model-based Fair Value estimate is HK$0.2600 — implying the stock looks roughly 37.3% overvalued today. We read business quality at 46/100 (below-average quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Over the trailing twelve months, 0844 generated revenue of HK$434M at a net margin of -20.4%. Revenue declined 20.0% year over year. It earns a return on equity of -44.2%. The balance sheet holds a net cash position of HK$33.0M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$434M

Revenue growth (YoY) -20.0%

Net margin -20.4%

Return on equity -44.2%

Free cash flow −HK$15.6M FY2025

Operating margin -9.2%

More key figures

EPS (TTM) HK$-0.0500

Net cash HK$33.0M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

0844 reported revenue of HK$434M in FY2025 versus HK$431M in FY2021, a compound +0.2%/yr. Reported net income was −HK$88.6M in FY2025.

Revenue +0.2%/yr

FY21 HK$431M

FY22 HK$469M

FY23 HK$509M

FY24 HK$487M

FY25 HK$434M

Net income

FY21 −HK$14.3M

FY22 −HK$156K

FY23 −HK$1.6M

FY24 −HK$14.5M

FY25 −HK$88.6M

Is 0844 fairly valued? → Check now

Similar stocks

6 more Apparel Manufacturing stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
H & M Hennes & Mauritz AB HMB	kr 166.80	kr 165.47	-1%
Ralph Lauren Corporation RL	$366.55	$365.78	-0%
Moncler S.p.A MONRY	$61.42	$42.18	-31%
Gildan Activewear Inc GIL	$58.41	$37.01	-37%
LPP SA LPP	18,350 PLN	20,063 PLN	+9%
Levi Strauss & Co LEVI	$22.95	$14.47	-37%

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 0844 (0844) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.2600 versus a price of HK$0.4150 — about −37% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 0844?

Our model-based fair value for 0844 is HK$0.2600 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.4150.

What is the quality score of 0844?

0844 has a Quality Score of 46/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 0844 (0844)?

0844 reported trailing-twelve-month revenue of about HK$434M (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 0844?

The net profit margin of 0844 is about -20.4%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.